SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, has entered an agreement with Memorial Sloan Kettering Cancer Center (MSK) to offer clinicians and researchers

Related Keywords

Don Granese ,Jurgi Camblong ,Kojo Sj Elenitoba Johnson ,Instagram ,Linkedin ,Twitter ,Media Communications ,Nasdaq ,Research Use ,Lab Medicine ,Department Of Pathology ,Facebook ,Genomic Panel ,Memorial Sloan Kettering Cancer Center ,Comprehensive Genomic Panel ,Healthcare Conference ,Research Use Only ,Looking Statements ,Sophia ,Enetics ,Reading ,Dancer ,Center ,Ollaborate ,Ombine ,Analysis ,Technology ,Liquid ,Biopsies ,